This report provides an in-depth analysis and market insights for the global pain management devices market. Rising incidence of chronic pain, chronic debilitating diseases and geriatric population pool play a vital role in the growing demand for pain management solutions worldwide. Lower side effects from use of devices than oral pain management solutions and surgeries also support the growth in demand for pain management devices. Technical innovations are expected to serve as future opportunities for growth of pain management devices market.

For the purpose of this study, the global pain management devices market is segmented for product types, applications and geography. In terms of product types, the global pain management is categorized into electrostimulation devices, radiofrequency ablation devices, infusion pumps and neurostimulation devices market. These segments are further categorized as:

•  Electrostimulaiton Devices
  • Transcutaneous electrical nerve stimulation (TENS)
  • Neuromuscular electrical stimulation (NMES)
  • Others
• Radiofrequency Ablation Devices
• Infusion Pumps
  • Intrathecal analgesic pumps
  • External analgesic pumps
• Neurostimulation Devices
  • Deep nerve stimulation
  • Sacral nerve stimulation
  • Vagus nerve stimulation
  • Spinal cord stimulation

Based on applications, this report studies the global pain management devices for applications in neuropathic pain, cancer pain, facial & migraine, musculoskeletal pain and others. This study provides market analysis and forecast for the mentioned segments for the period 2014-2022 with the respective compounded annual growth rates (CAGRs) for the period 2016-2022.

In terms of geographical distribution, the global pain management devices market is studied for North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America markets. Among these, the North America, Europe and Asia-Pacific markets are further studied for top national markets as follows: North America (U.S. & Canada), Europe (U.K., Germany & Rest of Europe), and Asia-Pacific (Japan, China & Rest of Asia-Pacific). Each of the covered regions and country level markets are studied in terms of their market size and forecast for the period 2014-2022 with their respective CAGRs for the period 2016-2022.

Along with the quantitative information sets, this report also includes qualitative market insights such as market dynamics: drivers, challenges and future market prospects. Competition assessment tools such as attractive investment proposition and fractal map analysis by key players are also provided in this study for investing the competition in the global pain management devices market. This report concludes with company profiles section that gives key information about major market player operating the pain management devices market.

The global pain management devices market is studied for the following device types:

• Electrostimulaiton Devices
  • Transcutaneous electrical nerve stimulation (TENS)
  • Neuromuscular electrical stimulation (NMES)
  • Others
• Radiofrequency Ablation Devices
• Infusion Pumps
  • Intrathecal analgesic pumps
  • External analgesic pumps
• Neurostimulation Devices
  • Deep nerve stimulation
  • Sacral nerve stimulation
  • Vagus nerve stimulation
  • Spinal cord stimulation

Among the mentioned device types, neurostimulation devices had the largest revenue share in 2015, due to wide usage neurostimulation devices for chronic pain management and higher preference for these devices due to their advanced technologies and efficiency in providing pain relief for long durations. On the other hand, radiofrequency ablation devices segment will register the fastest growth rate in the overall pain management devices market. Additionally, radiofrequency ablation also offers efficient relief from cancer pain thus facilitating the growth of this segment in cancer pain management.

The global pain management devices market is expected to be predominantly driven by the perpetual growth in geriatric population pool that bear a high risk of chronic diseases, cancer, inflammatory conditions, arthritis and others.

Neuropathic pain, cancer pain, facial & migraine, musculoskeletal pain and others cumulatively make the major application areas for pain management devices. Neuropathic pain is a significant application for pain management devices, treatments such as spinal cord stimulation and deep nerve stimulation play a vital role in treating several neurological conditions. Customization of stimulation levels, respective to the severity of the conditions and long term treatment efficacy significantly contribute to the growth of this segment. Radiofrequency ablation devices have proven efficiency in treating cancer pain through effectively terminating cancer cells by this means reducing cancer pain.

Geographically, the global pain management devices market is cumulative to North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

Following the trends of the global medical devices market, North America is the largest market for pain management devices followed by Europe. High prevalence of lifestyle diseases, cancer, osteoarthritis and the huge pool of high-risk geriatric population play a significant role in the dominance of North America and Europe pain management devices market. In addition, favorable reimbursement system and better awareness among patients and care-givers also assist in contributing to the demand for pain management devices in the regions. Asia-Pacific and Latin America with the rapid development of healthcare infrastructure will become the fastest growing markets for pain management devices during the forecast period.

The detailed classification of the global pain management devices market is as follows:

• North America (U.S. & Canada)
• Europe (U.K., Germany and Rest of Europe)
• Asia-Pacific (Japan, China and Rest of Asia-Pacific)
• Middle East and Africa
• Latin America